Should I buy CleanSpark (CLSK) stock or is it too late?
⭐ The most reliable of them, either direction: Chardan Capital — 75% of its targets hit on this sector (20 calls tested). It aims for $21 (+62 %), call made on August 11, 2026, maturing on August 11, 2027 (17 d ago).
Firm-by-firm track record on CleanSpark
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Chardan Capital | 71 % | +71.1 % | 17 | $21 +62% |
| BTIG | 40 % | +67.8 % | 5 | $26 +101% |
| Cantor Fitzgerald | 69 % | +65.5 % | 13 | $26 +101% |
| JP Morgan | 100 % | +53.2 % | 5 | $14 +8% |
| HC Wainwright & Co. | 38 % | +40.8 % | 16 | $27 +108% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $25, i.e. +93% from the current price ($13).
- The most reliable firm on CLSK, JP Morgan (100% hit rate, 5 scored calls), targets $14 (call made on November 24, 2025, maturing on November 24, 2026) (+8%) in its most recent call, and $14 (call made on September 26, 2025, maturing on September 26, 2026) (+8%) in the one coming due soonest.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on CLSK
Median target $25 (+93%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in CleanSpark now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $25 (+93%), and JP Morgan (most reliable on CLSK, 100%) targets $14. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in CleanSpark?
Not according to analysts: the median target ($25) is still +93% above the current price ($13) (most reliable on CLSK: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is CleanSpark still worth investing in?
It depends on the gap between the price ($13) and its estimated value: analysts target $25 on median (+93%), with 100% buys (most reliable on CLSK: JP Morgan, 100%). Cross-check with their real reliability on CLSK and the cautions above. Information, not advice.
What's the main risk in buying CLSK?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full CleanSpark profile (consensus, analyst reliability, price target, performance).